Publications by the researcher in collaboration with Miguel Ángel González-Gay Mantecón (19)

2021

  1. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study

    RMD Open, Vol. 7, Núm. 3

  2. Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596

2020

  1. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis

    Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2017

  1. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

  2. HDL cholesterol efflux capacity in rheumatoid arthritis patients: Contributing factors and relationship with subclinical atherosclerosis

    Arthritis Research and Therapy, Vol. 19, Núm. 1

2015

  1. Cardiovascular risk assessment in rheumatoid arthritis: What goals should be achieved?

    Seminars in Arthritis and Rheumatism

  2. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

  3. Vitamin D deficiency in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology [CARMA] study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

  4. Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 516-523

  5. Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 2, pp. 241-249

  6. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 618-626

2014

  1. Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 1, pp. 1-8

  2. Retinol-binding protein 4 in rheumatoid arthritis-related insulin resistance and β-cell function

    Journal of Rheumatology, Vol. 41, Núm. 4, pp. 658-665

2013

  1. Cholesteryl ester transfer protein in patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 40, Núm. 7, pp. 1040-1047

2012

  1. Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients

    Arthritis Research and Therapy, Vol. 15, Núm. 1

2011

  1. Resistencia insulínica y artritis reumatoide

    Reumatologia Clinica

  2. No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis

    Clinical and Experimental Rheumatology

  3. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis

    Annals of the Rheumatic Diseases